Literature DB >> 8264671

Detection of human rhinovirus RNA in nasal washings by PCR.

E Arruda1, F G Hayden.   

Abstract

A PCR assay was developed to detect human rhinovirus (HRV) RNA in nasal washings from individuals experimentally infected with HRV-39 or HRV strain Hanks. Total RNA was purified from samples stored in the presence of vanadyl ribonucleoside complex (VRC) by one of two methods: proteinase K digestion followed by multiple extractions with phenol/chloroform (PK-PC); or denaturation with guanidinium thiocyanate followed by one phenol/chloroform extraction (GTC). The limit of detection of HRV in nasal washings spiked with HRV-39 was lower with the GTC method (1 TCID50) than with the PK-PC method. In a study of 31 nasal washings extracted by the PK-PC method, the sensitivity (93%) and negative predictive value (94%) were sub-optimal in comparison to cell culture. In a study of 60 nasal washings extracted by the GTC method, the number of samples positive by PCR (25) exceeded by two the number positive by isolation in cell culture. A GTC-based method for HRV RNA extraction in nasal washings was superior to a proteinase K-phenol/chloroform-based method in regard to sensitivity, consumption of reagents, material and time.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8264671     DOI: 10.1006/mcpr.1993.1055

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  24 in total

1.  Improved detection of rhinoviruses in clinical samples by using a newly developed nested reverse transcription-PCR assay.

Authors:  A C Andeweg; T M Bestebroer; M Huybreghs; T G Kimman; J C de Jong
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

2.  Detection of rhinovirus in sinus brushings of patients with acute community-acquired sinusitis by reverse transcription-PCR.

Authors:  A Pitkäranta; E Arruda; H Malmberg; F G Hayden
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

Review 3.  Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory.

Authors:  M Ieven; H Goossens
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses.

Authors:  Daniel C Pevear; Frederick G Hayden; Tina M Demenczuk; Linda R Barone; Mark A McKinlay; Marc S Collett
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

5.  Epidemiologic evidence for Lancefield group C beta-hemolytic streptococci as a cause of exudative pharyngitis in college students.

Authors:  J C Turner; F G Hayden; M C Lobo; C E Ramirez; D Murren
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

6.  Detection of enteroviruses and rhinoviruses in clinical specimens by PCR and liquid-phase hybridization.

Authors:  P Halonen; E Rocha; J Hierholzer; B Holloway; T Hyypiä; P Hurskainen; M Pallansch
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

7.  Rapid detection of human rhinoviruses in nasopharyngeal aspirates by a microwell reverse transcription-PCR-hybridization assay.

Authors:  S Blomqvist; A Skyttä; M Roivainen; T Hovi
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

8.  Frequency and natural history of rhinovirus infections in adults during autumn.

Authors:  E Arruda; A Pitkäranta; T J Witek; C A Doyle; F G Hayden
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

9.  Amplicon sequencing and improved detection of human rhinovirus in respiratory samples.

Authors:  Christelle Deffernez; Werner Wunderli; Yves Thomas; Sabine Yerly; Luc Perrin; Laurent Kaiser
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

10.  Molecular diagnosis of human rhinovirus infections: comparison with virus isolation.

Authors:  T Hyypiä; T Puhakka; O Ruuskanen; M Mäkelä; A Arola; P Arstila
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.